4//SEC Filing
Slilaty Steve N. 4
Accession 0001683168-24-000879
CIK 0001402328other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:05 PM ET
Size
4.8 KB
Accession
0001683168-24-000879
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Purchase
Series B Preferred Stock
2024-02-08$0.10/sh+20,000$2,000→ 30,000 total
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeother
Related Parties
1- filerCIK 0001474684
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:05 PM ET
- Size
- 4.8 KB